In 2024, multiple drugs received complete response letters (CRLs), sometimes unrelated to the safety and efficacy of the drug ...

This year’s most-read articles on chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) explored treatment ...

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton ...

The top 5 most-viewed videos of 2024 highlighted advancements in therapies, heart disease screening, pediatric palliative ...

Check out this year's top coverage from The Academy of Managed Care Pharmacy (AMCP) Nexus 2024 meeting, which included ...

There are a number of considerations both in the short and long term to consider when making treatment decisions for younger ...

The top content from the Institute for Value-Based Medicine® (IVBM®) highlighted innovative approaches to improving care ...

Check out this year's top 5 pieces of sleep coverage that cover topics surveying the benefits of supplements, novel ...

This year’s most-read oncology content of 2024 includes topics on clinical trials, drug access, vaping and lung cancer, and ...

The approval of concizumab-mtci (Alhemo) injection marks a significant milestone in managing hemophilia A and B with ...

The high health care burden faced by individuals with hemophilia underscores the urgent need for innovative treatments and ...

In 2024, the most-read articles published in Population Health, Equity & Outcomes (PHEO) highlighted the promise of ...